Galectin Therapeutics
GALT
#8249
Rank
A$0.23 B
Marketcap
$3.84
Share price
0.79%
Change (1 day)
23.02%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2023 (TTM): -$0.99

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.99. In 2022 the company made an earnings per share (EPS) of -$0.98 a decrease over its 2021 EPS that were of -$0.78.

EPS history for Galectin Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.990.96%
2022-$0.9825%
2021-$0.7830%
2020-$0.60-6.98%
2019-$0.6513.16%
2018-$0.57-22.45%
2017-$0.74-35.53%
2016-$1.15-13.64%
2015-$1.3311.39%
2014-$1.19-39.69%
2013-$1.9781.94%
2012-$1.08-32.08%
2011-$1.607.07%
2010-$1.49-17.5%
2009-$1.81150%
2008-$0.72-68%
2007-$2.26127.27%
2006-$0.99-52.17%
2005-$2.08-20.69%
2004-$2.6252.63%
2003-$1.72-13.64%
2002-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$19.32 1,842.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.29-71.21%๐Ÿ‡บ๐Ÿ‡ธ USA